Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury

Introduction: Acute kidney injury (AKI) is a common clinical syndrome associated with high morbidity and mortality. Inhibition of the methyltransferase Enhancer of Zeste Homolog 2 (EZH2) by its inhibitor 3-DZNeP (3-Deazaneplanocin A) exerts renal benefits in acute renal ischemia-reperfusion injury (...

Full description

Bibliographic Details
Main Authors: Shanshan Zou, Jianing Chen, Peihui Zhou, Mengzhu Xue, Ming Wu, Li Wang
Format: Article
Language:English
Published: Karger Publishers 2024-02-01
Series:Kidney & Blood Pressure Research
Online Access:https://beta.karger.com/Article/FullText/537866
_version_ 1797262592187564032
author Shanshan Zou
Jianing Chen
Peihui Zhou
Mengzhu Xue
Ming Wu
Li Wang
author_facet Shanshan Zou
Jianing Chen
Peihui Zhou
Mengzhu Xue
Ming Wu
Li Wang
author_sort Shanshan Zou
collection DOAJ
description Introduction: Acute kidney injury (AKI) is a common clinical syndrome associated with high morbidity and mortality. Inhibition of the methyltransferase Enhancer of Zeste Homolog 2 (EZH2) by its inhibitor 3-DZNeP (3-Deazaneplanocin A) exerts renal benefits in acute renal ischemia-reperfusion injury (IRI). However, the underlying mechanisms is not completely known. This study aimed to elucidate the pathological mechanism of EZH2 in renal IRI by combination of multi-omics analysis and expression profiling in a public clinical cohort. Methods: In this study, C57BL/6J mice were used to establish acute kidney injury model, which were treated with 3-DZNeP for 24 hours. Kidney samples were collected for RNA-seq analysis, which was combined with publicly available EZH2-ChIP-seq data of mouse embryonic stem cell for a joint analysis to identify differentially expressed genes. Several selected differentially expressed genes were verified by quantitative PCR. Finally, single-nucleus sequencing data and expression profiling in public clinical datasets were used to confirm the negative correlation of the selected genes with EZH2 expression. Results: 3-DZNeP treatment significantly improved renal pathology and function in IRI mice. Through RNA-seq analysis combined with EZH2 ChIP-seq database, 162 differentially expressed genes were found, which might be involved in EZH2-mediated pathology in IRI kidneys. Four differential expressed genes (Scd1, Cidea, Ghr, and Kl) related to lipid metabolism or cell growth were selected based on GO and KEGG enrichment analysis, which were validated by quantitative PCR. Data from snRNA-seq revealed the negative correlation of these four genes with Ezh2 expression in different subpopulations of proximal tubular cells in IRI mice in different pattern. Finally, the negative correlation of these four genes with EZH2 expression was confirmed in patients with acute kidney injury in two clinical datasets. Conclusions: Our study indicates that Scd1, Cidea, Ghr, and Kl are downstream genes regulated by EZH2 in AKI. Upregulation of EZH2 in AKI inhibits the expression of these four genes in different population of proximal tubular cells to minimize normal physiological function, and promote acute or chronic cell injuries following acute kidney injury.
first_indexed 2024-03-07T19:39:33Z
format Article
id doaj.art-a880fb9057d24998b8340a0db37827f1
institution Directory Open Access Journal
issn 1423-0143
language English
last_indexed 2024-04-24T23:59:33Z
publishDate 2024-02-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-a880fb9057d24998b8340a0db37827f12024-03-14T08:00:36ZengKarger PublishersKidney & Blood Pressure Research1423-01432024-02-011110.1159/000537866537866Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion InjuryShanshan ZouJianing ChenPeihui ZhouMengzhu XueMing WuLi WangIntroduction: Acute kidney injury (AKI) is a common clinical syndrome associated with high morbidity and mortality. Inhibition of the methyltransferase Enhancer of Zeste Homolog 2 (EZH2) by its inhibitor 3-DZNeP (3-Deazaneplanocin A) exerts renal benefits in acute renal ischemia-reperfusion injury (IRI). However, the underlying mechanisms is not completely known. This study aimed to elucidate the pathological mechanism of EZH2 in renal IRI by combination of multi-omics analysis and expression profiling in a public clinical cohort. Methods: In this study, C57BL/6J mice were used to establish acute kidney injury model, which were treated with 3-DZNeP for 24 hours. Kidney samples were collected for RNA-seq analysis, which was combined with publicly available EZH2-ChIP-seq data of mouse embryonic stem cell for a joint analysis to identify differentially expressed genes. Several selected differentially expressed genes were verified by quantitative PCR. Finally, single-nucleus sequencing data and expression profiling in public clinical datasets were used to confirm the negative correlation of the selected genes with EZH2 expression. Results: 3-DZNeP treatment significantly improved renal pathology and function in IRI mice. Through RNA-seq analysis combined with EZH2 ChIP-seq database, 162 differentially expressed genes were found, which might be involved in EZH2-mediated pathology in IRI kidneys. Four differential expressed genes (Scd1, Cidea, Ghr, and Kl) related to lipid metabolism or cell growth were selected based on GO and KEGG enrichment analysis, which were validated by quantitative PCR. Data from snRNA-seq revealed the negative correlation of these four genes with Ezh2 expression in different subpopulations of proximal tubular cells in IRI mice in different pattern. Finally, the negative correlation of these four genes with EZH2 expression was confirmed in patients with acute kidney injury in two clinical datasets. Conclusions: Our study indicates that Scd1, Cidea, Ghr, and Kl are downstream genes regulated by EZH2 in AKI. Upregulation of EZH2 in AKI inhibits the expression of these four genes in different population of proximal tubular cells to minimize normal physiological function, and promote acute or chronic cell injuries following acute kidney injury.https://beta.karger.com/Article/FullText/537866
spellingShingle Shanshan Zou
Jianing Chen
Peihui Zhou
Mengzhu Xue
Ming Wu
Li Wang
Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
Kidney & Blood Pressure Research
title Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
title_full Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
title_fullStr Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
title_full_unstemmed Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
title_short Multi-omics Integrated Analysis of the Protective Effect of EZH2 inhibition in Mice with Renal Ischemia-Reperfusion Injury
title_sort multi omics integrated analysis of the protective effect of ezh2 inhibition in mice with renal ischemia reperfusion injury
url https://beta.karger.com/Article/FullText/537866
work_keys_str_mv AT shanshanzou multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury
AT jianingchen multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury
AT peihuizhou multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury
AT mengzhuxue multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury
AT mingwu multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury
AT liwang multiomicsintegratedanalysisoftheprotectiveeffectofezh2inhibitioninmicewithrenalischemiareperfusioninjury